ALTA3263

· Alterome Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALTA3263, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations [Phase 1]